Sowell Financial Services LLC Cara Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$12.38 - $29.19 $705 - $1,663	-57 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$15.07 - $21.71 $90 - $130	-6 Reduced 9.52%	57 $1,000
Q4 2020 Jan 13, 2021	SELL	$12.72 - $16.16 $38 - $48	-3 Reduced 4.55%	63 $1,000
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $308 - $448	-25 Reduced 27.47%	66 $1,000
Q1 2020 May 12, 2020	SELL	$9.12 - $17.78 $32,230 - $62,834	-3,534 Reduced 97.49%	91 $1,000
Q4 2019 Feb 07, 2020	BUY	$16.11 - $25.98 $56,932 - $91,813	3,534 Added 3883.52%	3,625 $58,000
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $1,663 - $2,448	91 New	91 $2,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.